0001209191-19-034780.txt : 20190605
0001209191-19-034780.hdr.sgml : 20190605
20190605165406
ACCESSION NUMBER: 0001209191-19-034780
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190603
FILED AS OF DATE: 20190605
DATE AS OF CHANGE: 20190605
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Holden Stuart
CENTRAL INDEX KEY: 0001763999
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38079
FILM NUMBER: 19880414
MAIL ADDRESS:
STREET 1: C/O UROGEN PHARMA LTD.
STREET 2: 9 HA'TA'ASIYA STREET
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UroGen Pharma Ltd.
CENTRAL INDEX KEY: 0001668243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
BUSINESS PHONE: 972 9 770 7601
MAIL ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-03
0
0001668243
UroGen Pharma Ltd.
URGN
0001763999
Holden Stuart
C/O UROGEN PHARMA LTD.
499 PARK AVENUE
NEW YORK CITY
NY
10022
1
0
0
0
Stock Option (Right to Buy)
34.83
2019-06-03
4
A
0
10000
0.00
A
2019-06-02
Ordinary Shares
10000
10000
D
The shares underlying the stock option will vest in equal quarterly installments over a period of two years.
/s/ Peter Pfreundschuh, Attorney-in-Fact
2019-06-05